Literature DB >> 14656175

Retrograde fenestration of endoluminal grafts from target vessels: feasibility, technique, and potential usage.

Richard G McWilliams1, Shirley J Fearn, Peter L Harris, David Hartley, James B Semmens, Michael M D Lawrence-Brown.   

Abstract

PURPOSE: To report initial experiments involving a new method for percutaneous intraprocedural stent-graft fenestration from the target vessel. TECHNIQUE: In bench and canine models, the fabric of an implanted Zenith endograft was punctured easily using the stiff end of a coronary 0.014-inch guidewire delivered through the target vessel (e.g., renal or iliac artery). A 20-G cutting needle was passed over the coronary wire to enlarge the puncture site, followed by a cutting balloon to create a fenestration that was of sufficient size to allow deployment of a stent.
CONCLUSIONS: In vivo endograft fenestration of a Zenith endograft is feasible. In addition to providing a percutaneous means of intentionally fenestrating a stent-graft from the artery to be perfused, the technique has potential application as a bailout maneuver after inadvertent side branch occlusion. Although the time to achieve successful fenestration in the experimental model was long, refinement may achieve performance times adequate to maintain viability of the end organ.

Entities:  

Mesh:

Year:  2003        PMID: 14656175     DOI: 10.1177/152660280301000518

Source DB:  PubMed          Journal:  J Endovasc Ther        ISSN: 1526-6028            Impact factor:   3.487


  2 in total

1.  Antegrade in situ fenestrated endovascular repair of a ruptured thoracoabdominal aortic aneurysm.

Authors:  Louis L Zhang; Fred A Weaver; Vincent L Rowe; Kenneth R Ziegler; Gregory A Magee; Sukgu M Han
Journal:  J Vasc Surg Cases Innov Tech       Date:  2020-05-28

2.  Evaluation for the safety and effectiveness of the in situ fenestration system in TEVAR for aortic arch pathologies: protocol for a prospective, multicentre and single-arm study.

Authors:  Xiaofan Sun; Yuanqing Kan; Lihong Huang; Zhihui Dong; Daqiao Guo; Yi Si; Weiguo Fu
Journal:  BMJ Open       Date:  2021-02-22       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.